unknown
Stage
1
Investors
About
Develops engineered heart tissue derived from stem cells — a "heart patch" intended to repair or regenerate damaged cardiac tissue for cardiology applications.
Explore APTARION BIOTECH AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.